BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2014
View Archived Issues
Nymox reports nerve sparing and sexual preservation data on NX-1207
Read More
Pfizer and Cellectis establish cancer immunotherapy collaboration
Read More
Kyowa Hakko Kirin to begin a phase I trial of KHK-6640 for Alzheimer's disease
Read More
Flexion reports pharmacokinetic results for FX-006 in knee osteoarthritis
Read More
First data presented for ZP-GG-72, a dual GLP-1/2 agonist
Read More
Biosimilar infliximab BOW-015 shows equivalence in phase III trial
Read More
ProMetic completes phase I trial of PBI-4050
Read More
Protalix BioTherapeutics initiates phase II study of PRX-112
Read More
Zalicus licenses sodium channel pain modulation program to AnaBios
Read More
MRC Technology sells melanocortin receptor program to Pfizer
Read More
Janssen enters into license agreement with Vertex for influenza A treatment
Read More
Ziarco secures grant from U.K.'s Technology Strategy Board to advance ZPL-389
Read More
Asmacure discloses topline results of phase I/IIa trial of ASM-024 dry powder inhaler
Read More
Global ALS/MND Day news: Compounds with surprising effects in experimental ALS
Read More
Novel agents for cancer disclosed by Agios Pharmaceuticals
Read More
Researchers at AbbVie disclose novel PDE10A inhibitors
Read More
Portuguese group divulges agents for tuberculosis
Read More
Novartis patents new monophosphate prodrugs for viral infections
Read More
Merck & Co. designs novel gamma-secretase inhibitors
Read More
AT-13148 well tolerated in ongoing first-in-human study
Read More
Novel Ga-68 PET bone-targeting agent tested in vivo, ex vivo and in metastatic bone cancer patients
Read More
Sumitomo Dainippon Pharma approved as new English trade name
Read More
FDA accepts Cubist's NDA for ceftolozane sulfate/tazobactam sodium
Read More
Intec Pharma reports animal safety data for the Accordion Pill for carbidopa/levodopa
Read More
Sorafenib approved in Japan for thyroid carcinoma
Read More
Shire rejects acquisition proposal from AbbVie
Read More